Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | CEO, Imaging | March 02, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 41,082 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 8,576 · Balance 41,082 F1: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.16 · Expires 2036-03-02 | Direct | 22,548 |
Reported balance
After 2026-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-02 · Grant · Acquired 22,548 · Balance 22,548 F3: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
F2: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
F3: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 3,727 | Not disclosed Strike: $57.74 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 10 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,727 Underlying: Common stock, par value $0.01 per share · 3,727 shares Expires 2029-03-19 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 13,275 | Not disclosed Strike: $40.40 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 9 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,275 Underlying: Common stock, par value $0.01 per share · 13,275 shares Expires 2028-12-21 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 2,296 | Not disclosed Strike: $76.66 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 8 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,296 Underlying: Common stock, par value $0.01 per share · 2,296 shares Expires 2028-03-19 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 1,639 | Not disclosed Strike: $76.66 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 7 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,639 Underlying: Common stock, par value $0.01 per share · 1,639 shares Expires 2028-03-19 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 13,773 | Not disclosed Strike: $88.67 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 6 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,773 Underlying: Common stock, par value $0.01 per share · 13,773 shares Expires 2028-01-29 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 919 | Not disclosed Strike: $99.21 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 5 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919 Underlying: Common stock, par value $0.01 per share · 919 shares Expires 2027-11-17 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 552 | Not disclosed Strike: $161.30 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552 Underlying: Common stock, par value $0.01 per share · 552 shares Expires 2026-09-30 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 735 | Not disclosed Strike: $135.92 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735 Underlying: Common stock, par value $0.01 per share · 735 shares Expires 2025-09-11 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 643 | Not disclosed Strike: $142.15 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643 Underlying: Common stock, par value $0.01 per share · 643 shares Expires 2024-09-05 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon stock, par value $0.01 per share | 245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.